CS logo
small CS logo
May Women's Health Clinic

Little Rock, Arkansas, United States

About May Women's Health Clinic


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Depomed
1
Pfizer
1
Total Rows: 2

Clinical Trials at May Women's Health Clinic


During the past decade, May Women's Health Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.
2008-10-01
2009-10-01
Completed
565
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
2011-05-01
2012-11-01
Completed
2,012

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsDepomed: 1Depomed: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at May Women's Health Clinic


According to Clinical.Site data, the most researched conditions in "May Women's Health Clinic" are "Hot Flashes" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "May Women's Health Clinic" in a lesser frequency.

Clinical Trials Intervention Types at May Women's Health Clinic


Most popular intervention types in "May Women's Health Clinic" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Fesoterodine 4mg" (1 trials), "Fesoterodine 8mg" (1 trials), "Gabapentin Extended-Release (G-ER) 1200 mg" (1 trials) and "Gabapentin Extended-Release (G-ER) 1800 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at May Women's Health Clinic


The vast majority of trials in "May Women's Health Clinic" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at May Women's Health Clinic


Currently, there are NaN active trials in "May Women's Health Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in May Women's Health Clinic, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in May Women's Health Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 1Phase 3: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2